| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |